Description
Contents
Fluticasone/Salmeterol
Indications/Uses
Asthma: Reversible Obstructive Airways Disease (ROAD):Β SERETIDE is indicated in the regular treatment of ROAD, including asthma in children and adults, where the use of a combination (bronchodilator and inhaled corticosteroid) is appropriate.
This may include: Patients on effective maintenance doses of long-acting beta-agonists and inhaled corticosteroids.
Patients who are symptomatic on current inhaled corticosteroid therapy.
Patients on regular bronchodilator therapy who require inhaled corticosteroids.
Chronic Obstructive Pulmonary Disease (COPD):Β SERETIDE is indicated for the Regular treatment of chronic obstructive pulmonary disease (COPD) including chronic bronchitis and emphysema.
Dosage/Direction for Use
Asthma (Reversible Obstructive Airways Disease):Β The dose should be titrated to the lowest dose at which effective control of symptoms is maintained. Where the control of symptoms is maintained with twice daily SERETIDE, titration to the lowest effective dose could include SERETIDE given once daily.
Patients should be given the strength of SERETIDE containing the appropriate fluticasone propionate dosage for the severity of their disease.
Patients should be given the strength of SERETIDE containing the appropriate fluticasone propionate dosage for the severity of their disease.
Evohaler:Β Recommended Doses: Adults and adolescents 12 years and older: Two inhalations of 25 micrograms salmeterol and 50 micrograms fluticasone propionate twice daily. or;
Two inhalations of 25 micrograms salmeterol and 125 micrograms fluticasone propionate twice daily. or;
Two inhalations of 25 micrograms salmeterol and 250 micrograms fluticasone twice daily.
Children 4 years and older: Two inhalations of 25 micrograms salmeterol and 50 micrograms fluticasone propionate twice daily.
There are no data available for use of SERETIDE in children aged under 4 years.
Chronic Obstructive Pulmonary Disease (COPD):Β For adult patients the recommended dose is two inhalations 25/125 micrograms to 25/250 micrograms salmeterol/fluticasone propionate twice daily.
Two inhalations of 25 micrograms salmeterol and 125 micrograms fluticasone propionate twice daily. or;
Two inhalations of 25 micrograms salmeterol and 250 micrograms fluticasone twice daily.
Children 4 years and older: Two inhalations of 25 micrograms salmeterol and 50 micrograms fluticasone propionate twice daily.
There are no data available for use of SERETIDE in children aged under 4 years.
Chronic Obstructive Pulmonary Disease (COPD):Β For adult patients the recommended dose is two inhalations 25/125 micrograms to 25/250 micrograms salmeterol/fluticasone propionate twice daily.
*The product images shown are for illustration purposes only and may not be an exact representation of the product.
